Physician profile
Rex D Cooley
NPI 1891760500
$46,820.67
in general payments reported to CMS, 2019-2025
21 companies · $7,358 in 2025
The $7,358 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,008 · 2020: $795 · 2021: $15K · 2022: $13K · 2023: $1,637 · 2024: $2,188 · 2025: $7,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,650.00 |
| Food and Beverage | $533.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $44,221.22 | 2019-2025 | Gmk Sphere |
| Stryker Corporation | $1,344.54 | 2019-2024 | Triathlon |
| Team_makena_llc | $305.65 | 2019-2021 | |
| Depuy Synthes Sales INC. | $174.40 | 2019-2024 | Na, Orthovisc, Monovisc |
| Orthofix Medical, INC. | $138.70 | 2019-2025 | Physio-Stim, Accelstim |
| Bioventus LLC | $117.50 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Encore Medical, Lp | $95.57 | 2023 | Djo Surgical |
| Smith+Nephew, INC. | $94.63 | 2019-2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Pacira Therapeutics, INC. | $72.61 | 2019 | |
| Embody, INC. | $53.72 | 2021 | |
| Integra Lifesciences Corporation | $47.65 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vertex Pharmaceuticals Incorporated | $22.77 | 2025 | |
| Anika Therapeutics, INC. | $21.25 | 2025 | Integrity Implant |
| Convatec INC. | $21.23 | 2024 | |
| Radius Health, INC. | $20.86 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $16.28 | 2023 | Krystexxa |
| Sanofi-Aventis U.S. LLC | $13.26 | 2019 | |
| Djo, LLC | $12.61 | 2020 | |
| Arthrosurface Incorporated | $11.14 | 2019 | |
| Merck Sharp & Dohme LLC | $11.05 | 2019 | |
| Illuminoss Medical, INC. | $4.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.